Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity
March 6, 2025
Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18
January 13, 2023
Related Post
-
-
Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
March 6, 2025
-
Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark
March 6, 2025
-
TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company
March 5, 2025